Deal facts
- Buyer
- Gilead Sciences, Inc.
- Target
- Arcellx, Inc.
- Deal value
- USD 7,100,000,000
- Announced
- 6 March 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash, earn-out
Sources
Deal timeline
1 update- CompletedClosed
Ravens Sub, Inc completes acquisition of Arcellx, Inc.
Introductory Note. As previously disclosed on February 23, 2026 in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “ SEC ”) by Arcellx, Inc., a Delaware corporation (the “ Company ”), the Company entered into an Agreement and Plan of Merger, dated as of February 22, 2026 (the “ Merger Agreement ”), by and among the Company, Gilead Sciences, Inc., a Delaware co
Source
For business owners
What would selling your own business involve?
Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.
Guides are free to read. Free tools require email access; indicative results are not professional advice.
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Merck KGaA, Darmstadt, Germany to acquire Silence Therapeutics plc
Merck KGaA, based in Darmstadt, Germany, has agreed to acquire Silence Therapeutics plc in a cash deal that will take the healthcare company private. The transaction, an…
- Buyer
- Merck KGaA, Darmstadt, Germany
- Target
- Silence Therapeutics plc
- Deal value
- Not disclosed
- Deal type
- going private
ArcheNova Technology Co., Ltd to acquire ArcheNova Biotech Corp.
ArcheNova Technology Co., Ltd has agreed to acquire ArcheNova Biotech Corp. in a transaction valued at two billion US dollars. The deal, announced on 13 October 2026, in…
- Buyer
- ArcheNova Technology Co., Ltd
- Target
- ArcheNova Biotech Corp.
- Deal value
- USD 2,000,000,000
- Deal type
- going private
Onyx Bidco LLC to acquire Option Care Health, Inc.
Option Care Health, Inc. entered into an Agreement and Plan of Merger on October 5, 2026 with Onyx Bidco LLC and its wholly owned subsidiary Onyx Merger Sub, Inc., both…
- Buyer
- Onyx Bidco LLC
- Target
- Option Care Health, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Lifecore Inc. to acquire Lifecore Biomedical, Inc.
Lifecore Inc. and Lifecore Biomedical, Inc. entered the Exit Mode archive.
- Buyer
- Lifecore Inc.
- Target
- Lifecore Biomedical, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
TULIP UK BIDCO LIMITED to acquire Spire Healthcare Group plc
TULIP UK BIDCO LIMITED has agreed to acquire Spire Healthcare Group plc in a going private transaction valued at approximately GBP 1.0265 billion. The deal structure inv…
- Buyer
- TULIP UK BIDCO LIMITED
- Target
- Spire Healthcare Group plc
- Deal value
- GBP 1,026,500,000
- Deal type
- going private
Buyer history
Gilead Sciences, Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive